On Health Policy

December 7, 2017. There is a need for new treatment options for interstitial cystitis and bladder pain syndrome (IC/BPS). These conditions have a range of causes and symptoms, and symptoms can be very similar to other conditions. This variation adds complexity to testing new treatments.  To meet the needs of patients, the FDA must hold the sponsors’ clinical trials to a high standard that ensures safe and effective treatments.

December 5, 2017. We strongly oppose the IFR’s use of religious objections to undermine essential health care for millions of women in our country. The HHS must ensure the health of all our citizens by implementing policies based on sound medical and public health science. We urge that HHS bring evidenced-based practice into the forefront of health policies, as it has for decades.

November 22, 2017. We urge CMS to focus on strategies which address the health needs of all Americans and provide opportunities for more access to quality care. We are particularly concerned that changes to the Navigator program would reduce enrollment in ways that could be detrimental to the health of many Americans.  

November 6, 2017. We support USPSTF’s draft recommendations for behavioral counseling interventions to prevent skin cancer as well as their broader efforts to improve the health of all Americans by making evidence-based recommendations about clinical preventive services. As more information becomes available, we encourage the provision of additional recommendations about more specific behavioral interventions to prevent skin cancer for individuals in various subgroups.